{
    "Trade/Device Name(s)": [
        "One Step Single/Multi-drug Test Cup",
        "One Step Single/Multi-drug Test Dipcard"
    ],
    "Submitter Information": "Co-Innovation Biotech Co., Ltd.",
    "510(k) Number": "K140748",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122809"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DJR",
        "DNK",
        "JXN",
        "LFG"
    ],
    "Summary Letter Date": "July 08, 2014",
    "Summary Letter Received Date": "July 09, 2014",
    "Submission Date": "August 14, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3620",
        "21 CFR 862.3640",
        "21 CFR 862.3700",
        "21 CFR 862.3910"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Methadone test system",
        "Morphine Test System",
        "Propoxyphene test system",
        "Tri-cyclic Antidepressants drug test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "2-ethylidene-1, 5-dimethyl-3,3-diphenylpyrrolidine (EDDP)",
        "Morphine",
        "Propoxyphene",
        "Tricyclic Antidepressants (Nortriptyline)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow chromatographic immunoassay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Immunochromatographic assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cup",
        "Dipcard"
    ],
    "Document Summary": "FDA 510(k) summary for Co-Innovation Biotech One Step Single/Multi-drug Test Cup and Dipcard, lateral flow assays for qualitative detection of drugs and metabolites in urine",
    "Indications for Use Summary": "Qualitatively detects drugs and drug metabolites (Buprenorphine, EDDP, Morphine, Propoxyphene, Tricyclic Antidepressants) in human urine using lateral flow immunoassay, for prescription and over-the-counter use including point of care sites.",
    "fda_folder": "Toxicology"
}